Suppliers / Jiangsu Tianhe Pharmaceutical

Jiangsu Tianhe Pharmaceutical

China Updated 9 July 2026

Jiangsu Tianhe Pharmaceutical is a contract manufacturer based in China. It holds 2 active US drug master files. Its most recent recorded inspection, by US FDA, closed on 3 August 2018 as VAI.

2
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 3 August 2018 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3010939885

What they file, and where

Molecule Regulators Docs
Sulfadimethoxine US FDA 2

Also appears on these molecule pages

Bupivacaine contract manufacturing

Questions about Jiangsu Tianhe Pharmaceutical

Does Jiangsu Tianhe Pharmaceutical hold a US DMF or a CEP?
Jiangsu Tianhe Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Jiangsu Tianhe Pharmaceutical FDA-registered?
One site operated by Jiangsu Tianhe Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Jiangsu Tianhe Pharmaceutical's last inspection go?
The most recent inspection on record closed on 3 August 2018 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Jiangsu Tianhe Pharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Jiangsu Tianhe Pharmaceutical make?
1 molecule is on record against Jiangsu Tianhe Pharmaceutical, including Sulfadimethoxine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Jiangsu Tianhe Pharmaceutical?

Ask Fred what the record holds on Jiangsu Tianhe Pharmaceutical, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Open risk flags

  • The most recent inspection outcome was VAI, on 3 August 2018.

Comparable suppliers

Aktin Pharmaceuticals also in China Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) also in China Anhui Wanhe Pharmaceutical also in China Anhui Worldbest Pharmaceutical also in China Asymchem Laboratories (Tianjin) also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability